OR WAIT null SECS
December 31, 2022
December 30, 2022
December 28, 2022
December 27, 2022
December 26, 2022
Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis
An expert-led podcast with a focus on clinical trials hosted by Muthiah Vaduganathan, MD, and Stephen Greene, MD
December 24, 2022
The December 2022 cardiology month in review features the announcement of CLEAR Outcomes meeting its primary end point, a pair of new scientific statements from the American Heart Association, and more!
December 23, 2022
Data from the nuMoM2b study suggests greater adherence to a Mediterranean diet was associated with reductions of 37%, 28%, and 21% in odds of gestational diabetes, preeclampsia, and any adverse pregnancy outcome, respectively, among a cohort of more than 7000 nulliparous women.
December 22, 2022
An observational study of data from patients with cancer treated with immune checkpoint inhibitors provides an overview of prognostic utility of noncardiac biomarkers for predicting myocarditis and all-cause mortality.
December 21, 2022
An analysis of data from the Japanese Collaborative Cohort Study for Evaluation of Cancer Risk suggests those with grade 2-3 hypertension could be increasing their risk of cardiovascular death by consuming 2 or more cups of coffee per day.
December 20, 2022
A single-center, retrospective analysis provides new insight into the role of social isolation and social frailty in the risk of negative outcomes among those hospitalized with heart failure.
December 19, 2022
On December 16, the world's foremost cardiology organizations released a joint opinion statement calling for a reinvention of clinical trials to better suit the needs of the healthcare system in the 21st century.
December 18, 2022
Negative perceptions of cardiology and a shift in preferences among internal medicine residents could be driving potential fellows away from careers in cardiology, according to a new study.
December 16, 2022
An analysis of data from randomized clinical trials and non-randomized trials comparing TAVI and surgery provides an overview of 5-year incidence, outcomes, and predictors of structural valve deterioration with both approaches.
December 15, 2022
December 14, 2022
An analysis of data from the MESA study sheds further light on associations of lipoprotein(a) and cardiovascular risk among a primary prevention cohort.